Evidence map›Paper›PMID 31568497›Full record

ArticlePLoS genetics2019

Ferritin heavy chain protects the developing wing from reactive oxygen species and ferroptosis.

Simone Mumbauer, Justine Pascual, Irina Kolotuev, Fisun Hamaratoglu

Erratum issuedAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 52 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Targeting ferroptosis for precision medicine in cervical cancer.Apoptosis : an international journal on programmed cell death · 2025
    Review
  10. Tick HRF-dependent ferroptosis pathway to promote tick acquisition ofFrontiers in cellular and infection microbiology · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Simone MumbauerCenter for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.
Justine PascualCenter for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-7787-7092
Irina KolotuevElectron Microscopy Facility, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-1433-8048
Fisun HamaratogluCenter for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-1461-9248

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interplay between signalling pathways and metabolism is crucial for tissue growth. Yet, it remains poorly understood. Here, we studied the consequences of modulating iron metabolism on the growth of Drosophila imaginal discs. We find that reducing the levels of the ferritin heavy chain in the larval wing discs leads to drastic growth defects, whereas light chain depletion causes only minor defects. Mutant cell clones for the heavy chain lack the ability to compete against Minute mutant cells. Reactive oxygen species (ROS) accumulate in wing discs with reduced heavy chain levels, causing severe mitochondrial defects and ferroptosis. Preventing ROS accumulation alleviates some of the growth defects. We propose that the increased expression of ferritin in hippo mutant cells may protect against ROS accumulation.

Indexed as

AnimalsApoferritinsCell DeathCells, CulturedDrosophilaDrosophila ProteinsFerroptosisImaginal DiscsIronMitochondriaReactive Oxygen SpeciesSignal TransductionWings, AnimalApoferritinsDrosophila ProteinsIronReactive Oxygen Species

Identifiers

PMID31568497
PMCPMC6786644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.